Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $21.8900 (-1.57%) ($21.3900 - $22.1800) on Mon. Aug. 12, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.91% (three month average) | RSI | 24 | Latest Price | $21.8900(-1.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.5% a day on average for past five trading days. | Weekly Trend | IOVA declines -6.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(49%) XBI(49%) ARKG(47%) IWO(44%) ARKK(42%) | Factors Impacting IOVA price | IOVA will decline at least -2.955% in a week (0% probabilities). VIXM(-28%) VXX(-16%) UUP(-9%) IFRA(-6%) TLT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.955% (StdDev 5.91%) | Hourly BBV | 0 () | Intraday Trend | -0.4% | | | |
|
1 - 5 Day Possible Target | $12.04(-45%) | Resistance Level | $24.11 | 5 Day Moving Average | $22.18(-1.31%) | 10 Day Moving Average | $23.1(-5.24%) | 20 Day Moving Average | $24.11(-9.21%) | To recent high | -15.8% | To recent low | 115.2% | Market Cap | $3.205b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |